• Ru
  • En
  • Our team

    The company's management is distinguished by professionalism, focus on results and commitment to the most stringent ethical standards of doing business.

    Yuri Raifeld


    Elena Brin

    General Director

    Dmitry Dmitriev

    Financial Director

    Yuri Raifeld

    Prof. Raifeld has over 30 years of successful senior management experience in healthcare. In a few short years, he grew Lagopharm to become a professional service provider, consistently recognized for quality, outstanding expertise, and strong ethical character.

    Prior to founding Lagopharm, Prof. Raifeld served as President and Chief Operating Officer for ClinStar, a leading Russian Clinical Research Organization, which he co-founded and grew to over 200 employees in Russia, Ukraine, and the US. Before ClinStar, Prof. Raifeld worked for seven years at Wyeth in the US, where he oversaw a team of 30 researches who successfully developed and patented a new type of RSV inhibitors.

    Before starting his career in business, Prof. Raifeld founded and headed a laboratory for total synthesis of biologically-active compounds at Moscow Institute of Fine Chemical Technology (MIFCT). He has published extensively in Russian and international scientific journals, with over 120 articles and reviews and 20 patents to his name.

    Prof. Raifeld received his M.S., Ph.D., and Dr. Sci. degrees from MIFCT.

    Elena Brin

    Elena graduated from the North-Ossetian State Medical Academy as an MD. After completing post-graduate studies at the Pirogov Russian National Research Medical University, Elena obtained a PhD in medicine and served as a professor at the Department of Pharmacology. Elena got her business degree (MBA) at Moscow State University of Economics, Statistics and Informatics.

    Elena started her career in the pharmaceutical industry in 1993 as a medical representative of Boehringer Ingelheim. Further, Elena held senior jobs in sales and marketing at such large companies as Schering-Plough, Lechiva, and GlaxoSmithKline. Between 2009 and 2019, Elena served as General Director of the Actelion pharmaceuticals RUS company.

    Since May 2019, Elena has held the position of General Director of Lagopharm. As General Director, Elena provides overall management and monitoring of Lagopharm’s activities.

    Dmitry Dmitriev

    Dr. Dmitriev used his over 20 years of leadership experience in the Russian pharmaceutical industry to establish a solid foundation at Raifarm and continue to develop and grow the company.

    Before joining Lagopharm, Dr. Dmitriev headed PharmaNet’s Russian office, as Director of Clinical Research, supervising a team of 35 professionals in Moscow, St. Petersburg, and Novosibirsk. Before that, he was head of clinical operations for Pfizer in Moscow. Consistently recognized for his managerial strength, he was awarded Best Team Leader, Pfizer Russia.

    Dr. Dmitriev taught for nine years at Russian State Medical University, ultimately reaching Associate Professor of Medicine. He has extensive experience as a practicing cardiologist and is responsible for over 40 publications, one monograph, and five patents.

    Dr. Dmitriev received his M.D. and Ph.D. degrees from Russian State Medical University, and has an MBA from the UK’s Open University.